Increased serum malondialdehyde levels in chronic stage of ischemic stroke

Tohoku Journal of Experimental Medicine

Volumn 208, Issue 1, 2005, Pages 33-39

  Bir, Levent Sinan ^a   Demir, Süleyman ^a   Rota, Simin ^a,c   Köseoǧlu, Mehmet ^b  

^a PAMUKKALE UNIVERSITY   (Turkey)

^b ATATURK TRAINING AND RESEARCH HOSPITAL   (Turkey)

^c NONE   (Turkey)

Author keywords

Chronic stroke; Ischemic stroke; Malondialdehyde; MDA; Oxidative stress

Indexed keywords

MALONALDEHYDE;

ADULT; AGED; ARTICLE; BLOOD LEVEL; BRAIN ATHEROSCLEROSIS; BRAIN INFARCTION; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR DISEASE; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DYSLIPIDEMIA; FEMALE; HUMAN; HYPERTENSION; MALE; OCCLUSIVE CEREBROVASCULAR DISEASE; STATISTICAL SIGNIFICANCE; VOLUNTEER;

ADULT; AGED; CEREBROVASCULAR ACCIDENT; FEMALE; HUMANS; ISCHEMIA; MALE; MALONDIALDEHYDE; MIDDLE AGED; TIME FACTORS;

EID: 29144463741     PISSN: 00408727     EISSN: 13493329     Source Type: Journal    
DOI: 10.1620/tjem.208.33     Document Type: Article

References (23)

1. Alexandrova, M.L., Bochev, P.G., Markova, V.I., Bechev, B.G., Popova, M.A., Danovska, M.P. & Simeonova, V.K. (2003) Oxidative stress in the chronic phase after stroke. Redox Report., 8, 169-176.
2. Alexandrova, M.L. & Bochev, P.G. (2005) Oxidative stress during the chronic phase of stroke. Free Rad. Biol. Med., 39, 297-316.
3. Belch, J., Mc Laren, M., Hanslip, J., Hill, A. & Davidson, D. (1998) The white blood cell and plasma fibrinogen in thrombotic stroke: a significant correlation. Int. Angiol., 17, 120-124.
4. Bolokadze, N., Lobjanidze, I., Momtselidze, N., Solomonia, R., Shakarishvili, R. & McHedlishvili, G. (2004) Blood rheological properties and lipidperoxidation in cerebral and systemic circulation of neurocritical patients. Clin. Hemorheol. Microcirc., 30, 99-105.
5. Bonithon-Kopp, C., Coudray, C., Berr, C., Touboul, P.J., Feve, J.M., Favier, A. & Ducimetiere, P. (1997) Combined effects of lipid peroxidation and antioxidant status on carotid atherosclerosis in a population aged 59-71 y: The EVA Study. Etude sur le Vieillisement Arteriel. Am. J. Clin. Nutr., 65, 121-127.
6. Cherubini, A., Ruggiero, C., Polidori, C. & Mecocci, P. (2005) Potential markers of oxidative stress in stroke. Free Rad. Biol. Med., 39, 841-852.
7. Davidenkova, E.F., Shafran, M.G. & Veksler, B.M. (1990) Indicators of lipid peroxidation in the blood in hereditary predisposition to arteriosclerosis. Klin. Med. (Mosk)., 68, 34-38.
8. DeGraba, T.J., Fisher, M. & Yatsu, F.M. (1992) Atherogenesis and strokes. In: Stroke Pathophysiology, Diagnosis and Management. 2nd ed., edited by H.J.M. Barnett, J.P. Mohr, B.M. Stein & F.M. Yatsu. Churchill Livingstone, NY, pp. 29-48.
9. Demirkaya, S., Topçuoglu, M.A, Aydin, A., Ulas, U.H., Isimer, A.L. & Vural, O. (2001) Malondialdehyde, glutathione peroxidase and superoxide dismutase in peripheral blood erytrocytes of patients with acute cerebral ischemia. Eur. J. Neurol., 8, 43-51.
10. Dotan, Y., Lichtenberg, D. & Pinchuk, I. (2004) Lipid peroxidation cannot be used as a universal criterion of oxidative stress. Prog. Lipid Res., 43, 200-227.
11. Garcia, J.H., Ho, K.L. & Caccamo, D.V. (1992) Pathology of stroke. In: Stroke Pathophysiology, Diagnosis and Management 2nd ed., edited by H.J.M. Barnett, J.P. Mohr, B.M. Stein & F.M. Yatsu. Churchill Livingstone, NY, pp. 125-145.
12. Iavorskaia, V.A., Belous, A.M. & Mokhamed, A.N. (2000) The level of middle mass molecules and lipid peroxation in blood of patients with different forms of stroke. Zh. Nevrol. Psikhiatr. Im. S. S. Korsakova, 100, 48-51.
13. Mezzetti, A., Zuliani, G., Romano, F., Costantini, F., Pierdomenico, S.D., Cuccurullo, F., Fellin, R. & Associazione Medica Sabin (2001) Vitamin E and lipid peroxide plasma levels predict the risk of cardiovascular accidents in a group of healthy very old people. J. Am. Geriatr. Soc., 49, 533-537.
14. Mohr, J.P. (1992) Lacunes In: Stroke Pathophysiology, Diagnosis and Management 2nd ed., edited by H.J.M. Barnett, J.P. Mohr, B.M. Stein & F.M. Yatsu. Churchill Livingstone, NY, pp. 539-560.
15. Mohr, J.P. & Sacco, R.L. (1992) Classification of ischemic strokes. In: Stroke Pathophysiology, Diagnosis and Management 2nd ed., edited by H.J.M. Barnett, J.P. Mohr, B.M. Stein & F.M. Yatsu. Churchill Livingstone, NY, pp. 271-283.
16. Ohkawa, H., Ohishi, N. & Yagi, K. (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem., 95, 351-358.
17. Polidori, M.C., Cherubini, A., Stahl, W., Senin, U., Sies, H. & Mecocci, P. (2002) Plasma carotenoid and malondialdehyde levels in ischemic stroke patients: relationship to early outcome. Free Radic. Res., 36, 265-268.
18. Re, G., Azzimondi, G., Lanzarini, C., Bassein, L., Vanoa, I. & Guarnieri, C. (1997) Plasma lipoperoxidative markers in ischaemic stroke suggest brain embolism. Eur. J. Emerg. Med., 4, 5-9.
19. Sacco, R.L. (2000) Pathogenesis, classification, and epidemiology of cerebrovascular disease. In: Merrits's Neurology. 10th ed., edited by L.P. Rowland. Lippincot Williams & Wilkins, NY, pp. 217-229.
20. Sharpe, P.C., Mulholland, C. & Trinick, T. (1994) Ascorbate and malondialdehyde in stroke patients. Ir. J. Med. Sci., 163, 488-491.
21. Tamam, Y., Iltumur, K. & Apak, I. (2005) Assessment of acute phase proteins in acute ischemic stroke. Tohoku J. Exp. Med., 206, 91-98.
22. Walter, M.F., Jacob, R.F, Jeffers, B., Ghadanfar, M.M., Preston, G.M., Buch, J. & Mason, R.P. (2004) Serum levels of thiobarbituric acid reactive substances predict cardiovascular accidents in patients with stable coronary artery disease: a longitudinal analysis of the PRACCIDENT study. J. Am. Coll. Cardiol., 44, 1996-2002.
23. Wehr, H., Ryglewicz, D., Rodo, M., Pozniak, M., Swiderska, M., Panczenko, B. & Stajniak, A. (2000) In vitro oxidation of low density lipoproteins in patients after ischemic stroke. Neurol. Neurochir. Pol., 34, 447-456.